BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.580
-0.010 (-0.63%)
Apr 28, 2026, 4:00 PM EDT - Market closed
BioVie Employees
BioVie had 13 employees as of June 30, 2025. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
-$1,344,472
Market Cap
11.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| Imunon | 25 |
| BioLineRx | 24 |
| Reviva Pharmaceuticals Holdings | 14 |
| Kiora Pharmaceuticals | 13 |
| Cellectar Biosciences | 11 |
| Aprea Therapeutics | 8 |
BIVI News
- 1 day ago - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 - GlobeNewsWire
- 12 days ago - BioVie Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts
- 14 days ago - BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting - GlobeNewsWire
- 7 weeks ago - BioVie Transcript: Status update - Transcripts
- 2 months ago - Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 4 months ago - HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 5 months ago - Join Biovie's Exclusive Live Investor Webinar and Q&A Session on December 9 - GlobeNewsWire
- 6 months ago - BioVie Transcript: AGM 2025 - Transcripts